JP2003528887A5 - - Google Patents

Download PDF

Info

Publication number
JP2003528887A5
JP2003528887A5 JP2001571713A JP2001571713A JP2003528887A5 JP 2003528887 A5 JP2003528887 A5 JP 2003528887A5 JP 2001571713 A JP2001571713 A JP 2001571713A JP 2001571713 A JP2001571713 A JP 2001571713A JP 2003528887 A5 JP2003528887 A5 JP 2003528887A5
Authority
JP
Japan
Prior art keywords
vaccine according
peptide
human cytomegalovirus
vaccine
modulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001571713A
Other languages
English (en)
Japanese (ja)
Other versions
JP5602332B2 (ja
JP2003528887A (ja
Filing date
Publication date
Priority claimed from US09/534,639 external-priority patent/US6251399B1/en
Priority claimed from US09/692,170 external-priority patent/US6562345B1/en
Application filed filed Critical
Publication of JP2003528887A publication Critical patent/JP2003528887A/ja
Publication of JP2003528887A5 publication Critical patent/JP2003528887A5/ja
Application granted granted Critical
Publication of JP5602332B2 publication Critical patent/JP5602332B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2001571713A 2000-03-27 2001-03-16 ヒトサイトメガロウイルスの免疫ー反応性ペプチドｃｔｌエピトープ Expired - Lifetime JP5602332B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/534,639 2000-03-27
US09/534,639 US6251399B1 (en) 1996-11-12 2000-03-27 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
US09/692,170 2000-10-20
US09/692,170 US6562345B1 (en) 1996-11-12 2000-10-20 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
PCT/US2001/008576 WO2001072782A2 (en) 2000-03-27 2001-03-16 Immuno-reactive peptide ctl epitopes of human cytomegalovirus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011243962A Division JP5731952B2 (ja) 2000-03-27 2011-11-07 ヒトサイトメガロウイルスの免疫ー反応性ペプチドｃｔｌエピトープ

Publications (3)

Publication Number Publication Date
JP2003528887A JP2003528887A (ja) 2003-09-30
JP2003528887A5 true JP2003528887A5 (https=) 2007-06-28
JP5602332B2 JP5602332B2 (ja) 2014-10-08

Family

ID=27064538

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001571713A Expired - Lifetime JP5602332B2 (ja) 2000-03-27 2001-03-16 ヒトサイトメガロウイルスの免疫ー反応性ペプチドｃｔｌエピトープ

Country Status (6)

Country Link
US (6) US6562345B1 (https=)
EP (1) EP1268529A2 (https=)
JP (1) JP5602332B2 (https=)
AU (2) AU2001249243B2 (https=)
CA (1) CA2401638C (https=)
WO (1) WO2001072782A2 (https=)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7935675B1 (en) * 1994-07-15 2011-05-03 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6207646B1 (en) * 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US20040171028A1 (en) * 1996-06-06 2004-09-02 Baker Brenda F. Phosphorous-linked oligomeric compounds and their use in gene modulation
US6632435B1 (en) * 1999-10-20 2003-10-14 City Of Hope CTL epitope analogs
US20040191260A1 (en) 2003-03-26 2004-09-30 Technion Research & Development Foundation Ltd. Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
US8022190B2 (en) 2001-06-19 2011-09-20 Technion Research & Development Foundation Ltd. Immuno-molecules containing viral proteins, compositions thereof and methods of using
AUPR593101A0 (en) 2001-06-26 2001-07-19 Council Of The Queensland Institute Of Medical Research, The Cytomegalovirus t cell epitopes
WO2003073097A2 (en) * 2002-02-28 2003-09-04 Intercell Ag Methods for isolating ligands e.g. t cell epitopes
US8895020B2 (en) * 2002-04-19 2014-11-25 Washington University Single chain trimers and uses therefor
WO2004000873A2 (en) * 2002-06-25 2003-12-31 City Of Hope Adjuvant-free peptide vaccine
CA2484941A1 (en) 2002-07-24 2004-02-05 Intercell Ag Antigens encoded by alternative reading frame from pathogenic viruses
EP2402026A3 (en) 2002-09-13 2012-04-18 Intercell AG Method for isolating hepatitis C virus peptides
US20040072262A1 (en) * 2002-10-11 2004-04-15 Montero-Julian Felix A. Methods and systems for detecting MHC class I binding peptides
ATE485056T1 (de) 2003-03-24 2010-11-15 Intercell Ag Verbesserte impfstoffe
US7163685B2 (en) * 2003-04-16 2007-01-16 City Of Hope Human cytomegalovirus antigens expressed in MVA and methods of use
US20050232933A1 (en) * 2003-09-30 2005-10-20 Zaia John A CMV-IE1 peptides and method of use
JP2007511760A (ja) * 2003-11-03 2007-05-10 ベックマン コールター インコーポレーティッド Ｍｈｃ結合ペプチドを検出するための溶液ベースの方法
US9090673B2 (en) * 2003-12-12 2015-07-28 City Of Hope Synthetic conjugate of CpG DNA and T-help/CTL peptide
JP2007536522A (ja) * 2004-05-07 2007-12-13 ベックマン コールター インコーポレーティッド Ｃｔｌの媒介による抗原提示細胞の溶解を検出するためのｍｈｃ架橋系
US7678379B2 (en) * 2004-06-17 2010-03-16 Beckman Coulter, Inc. Mycobacterium tuberculosis epitopes and methods of use thereof
WO2006101909A2 (en) * 2005-03-16 2006-09-28 Ischemix, Inc. Combination therapy for treating or preventing diseases
US8518697B2 (en) * 2006-04-04 2013-08-27 Washington University Single chain trimers and uses therefor
US7977457B2 (en) * 2006-05-19 2011-07-12 Teva Pharmaceutical Industries Ltd. Fusion proteins, uses thereof and processes for producing same
US20080138354A1 (en) * 2006-07-21 2008-06-12 City Of Hope Cytomegalovirus vaccine
EP2361930A3 (en) 2007-03-26 2011-10-26 Dako Denmark A/S Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases
EP3620465B1 (en) 2007-07-03 2025-02-19 Dako Denmark A/S Improved methods for generation, labeling and use of mhc multimers
US10611818B2 (en) 2007-09-27 2020-04-07 Agilent Technologies, Inc. MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
DK2254592T3 (da) 2008-02-28 2019-09-09 Dako Denmark As MHC-multimerer til Borrelia-diagnostik og sygdom
CA2728739C (en) 2008-06-20 2017-07-11 Duke University Use of human cytomegalovirus antigens to enhance immune responses to cancer cells
US10722562B2 (en) 2008-07-23 2020-07-28 Immudex Aps Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
WO2010037397A1 (en) * 2008-10-01 2010-04-08 Dako Denmark A/S Mhc multimers in cmv immune monitoring
WO2010037402A1 (en) 2008-10-02 2010-04-08 Dako Denmark A/S Molecular vaccines for infectious disease
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
ES2912042T3 (es) 2011-06-24 2022-05-24 Nono Inc Terapia de combinación para isquemia
US9241970B2 (en) * 2011-12-13 2016-01-26 Nono Inc. Therapy for subarachnoid hemorrhage and ischemia
EP3049092A4 (en) * 2013-09-24 2017-09-06 Duke University Compositions, methods and kits for eliciting an immune response
US10023626B2 (en) 2013-09-30 2018-07-17 Modernatx, Inc. Polynucleotides encoding immune modulating polypeptides
EP3364981A4 (en) 2015-10-22 2019-08-07 ModernaTX, Inc. VACCINE AGAINST THE HUMAN CYTOMEGALOVIRUS
US10611800B2 (en) 2016-03-11 2020-04-07 Pfizer Inc. Human cytomegalovirus gB polypeptide
MA46584A (fr) 2016-10-21 2019-08-28 Modernatx Inc Vaccin contre le cytomégalovirus humain
EP3706783A1 (en) * 2017-11-06 2020-09-16 The United States of America, as represented by the Secretary, Department of Health and Human Services Cancer treatment utilizing pre-existing microbial immunity
CN109748952B (zh) * 2018-05-02 2020-09-15 中国药科大学 辅助性表位肽及其应用
US12258373B2 (en) 2018-12-17 2025-03-25 Immudex Aps Panel comprising Borrelia MHC multimers
US11629172B2 (en) 2018-12-21 2023-04-18 Pfizer Inc. Human cytomegalovirus gB polypeptide
TWI810589B (zh) 2020-06-21 2023-08-01 美商輝瑞股份有限公司 人巨細胞病毒糖蛋白Ｂ（ｇＢ）多肽
US11406703B2 (en) 2020-08-25 2022-08-09 Modernatx, Inc. Human cytomegalovirus vaccine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4762780A (en) 1984-04-17 1988-08-09 The Regents Of The University Of California Method and composition for screening and diagnosing "HCMV"
GB8404368D0 (en) 1984-02-20 1984-03-28 Cogent Ltd Monoclonal antibodies to human cytomegalovirus
US5075213A (en) 1984-07-27 1991-12-24 City Of Hope Method for detection and prevention of human cytomegalovirus infection
US6207161B1 (en) * 1986-07-16 2001-03-27 City Of Hope Induction of cytolytic T-lymphocytes with cytomegalovirus polypeptides
WO1994000150A1 (en) 1992-06-25 1994-01-06 City Of Hope Induction of cytolytic t-lymphocytes with cytomegalovirus polypeptides
AU651397B2 (en) 1990-09-28 1994-07-21 Fred Hutchinson Cancer Research Center Method for producing TH-independent cytotoxic T lymphocytes
US5470730A (en) 1990-09-28 1995-11-28 Immunex Method for producing TH -independent cytotoxic T lymphocytes
US5405940A (en) 1992-08-31 1995-04-11 Ludwig Institute For Cancer Research Isolated nonapeptides derived from MAGE genes and uses thereof
AU698962B2 (en) 1993-09-14 1998-11-12 Epimmune, Inc. Alteration of immune response using pan DR-binding peptides
US5827642A (en) 1994-08-31 1998-10-27 Fred Hutchinson Cancer Research Center Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
US5635363A (en) 1995-02-28 1997-06-03 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for the detection, quantitation and purification of antigen-specific T cells
US6448389B1 (en) 1996-04-23 2002-09-10 The Wistar Institute Of Anatomy And Biology Human cytomegalovirus DNA constructs and uses therefor
US6156317A (en) 1996-11-12 2000-12-05 City Of Hope Immuno-reactive peptide CTL epitopes of human cytomegalovirus
US6074645A (en) 1996-11-12 2000-06-13 City Of Hope Immuno-reactive peptide CTL epitopes of human cytomegalovirus
FR2757169B1 (fr) 1996-12-13 1999-03-05 Inst Nat Sante Rech Med Proteine de fusion comportant tout ou partie de la proteine pp65 de cmv humain, utile notamment dans la preparation d'un vaccin
ATE497971T1 (de) 1999-06-04 2011-02-15 Florian Kern Peptide zur vakzinierung gegen das humane cmv

Similar Documents

Publication Publication Date Title
JP2003528887A5 (https=)
UY25146A1 (es) Proteínas de fusión hpv comprendiendo una proteína e6, e7 o e6e7 fusionada con una proteína d de haemophilus influenzae b o derivados de la misma y composiciones para uso como vacunas que las comprenden
JP2001516569A5 (https=)
IL150602A (en) Proteosome influenza vaccine, method for preparing such and use thereof
CA2391843A1 (en) Hcv vaccine compositions
WO1998037095A3 (en) Recombinant pox virus for immunization against muc1 tumor-associated antigen
CA2253636A1 (en) Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
WO2002034205A3 (en) Using heat shock proteins to increase immune response
Lingnau et al. Poly-L-arginine synergizes with oligodeoxynucleotides containing CpG-motifs (CpG-ODN) for enhanced and prolonged immune responses and prevents the CpG-ODN-induced systemic release of pro-inflammatory cytokines
JP2002542827A5 (https=)
CA2395499A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
RU2003103779A (ru) Экспрессионная система
CO4650186A1 (es) Composicion de vacuna
WO2002034287A3 (en) Therapeutic vaccine formulations containing chitosan
MX9801089A (es) Proteina hibrida que comprende epitopes estimulantes de celula auxiliar t y epitopes de celula b de la proteina de membrana externa mayor chlamydia trachomatis y su uso como vacuna.
EP0236977A3 (en) Bovine virus diarrhea and hog cholera vaccines
EP1829552A3 (en) Chlamydia PMP proteins, gene sequences and uses thereof
WO2001010469A3 (en) Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines
ATE494377T1 (de) Vakzine gegen ipnv die aus hefezellen isoliert werden
WO2002036611A3 (en) Immunomodulatory peptides derived from heat shock proteins and uses thereof
IL141443A0 (en) Vaccine comprising cytokine-induced heat shock proteins (hsp)
CA2516661A1 (en) M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever
Behboudi et al. Dendritic cells infected by recombinant modified vaccinia virus Ankara retain immunogenicity in vivo despite in vitro dysfunction
WO2002069691A3 (en) Immunogenic hiv peptides for use as reagents and vaccines
WO2002051237A3 (en) Helicobacter proteins, nucleic acids and uses thereof